Dr. Lal PathLabs Ltd

Desk›Healthcare› Dr. Lal PathLabs Ltd

BSE 539524 · NSE LALPATHLAB · ISIN INE600L01024 · Group A · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

₹1,930.70

-0.41%

BSE close, 28 August 2026

Market cap

₹32,406.57 cr

16.8 cr shares · Mid cap

Free float

₹15,004.47 cr

as published

P/E · P/B

59.4× · 15.60×

EPS ₹32.50 · BV ₹123.76

FY25-26 rev / PAT

2,647.60 / 508.20

₹ cr, as filed

Filings, window

10 selected · 45%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-2.9%
Against 52-week low	+51.8%
Day change	-0.41%
Size band	Mid cap
Index membership	NIFTY 500

Valuation as published by BSE

Earnings per share	₹32.50
Price / earnings	59.41×
Price / book	15.60×
Book value — derived, price ÷ P/B	₹123.76
Return on equity	26.26%
Operating margin	35.11%
Net margin	21.70%

Consistency check

P/B ÷ P/E, which must equal ROE: 26.26%
ROE as published: 26.26%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	764.40	165.90	9.94	35.11%	21.70%
Mar-26 · Q	675.20	141.10	8.45	32.36%	20.90%
FY25-26	2,647.60	508.20	30.45	31.59%	19.19%

Quarter on quarter

Revenue, quarter on quarter: +13.2%
Net profit, quarter on quarter: +17.6%
Operating margin, quarter on quarter: +275 bps

Disclosure profile 22 filings in the window

Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Acquisition	4
Board Outcome	1
Concall Transcript	1
Dividend	1
Investor Presentation	1
Press Release	1
Results	1
Selected sub-total	10
Procedural
General	3
Analyst / Investor Meet	1
Board Meeting	1
Compliance Certificate	1
Corporate Action	1
ESOP Allotment	1
Newspaper Publication	1
Outcome	1
Record Date	1
Trading Window	1
Procedural sub-total	12
Total	22

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

22 filings · 10 selected · busiest 2026-07-24

Filing rhythm · the twelve most recent

2026-07-302026-10-09

SelectedProcedural

Filings

22 in the window · 14 earlier on record

9 October 2026 · 16:16 IST

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attached

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
8 October 2026 · 13:11 IST

General

Intimation Under Regulation 30

Attached

Company Update / General View filing →
1 October 2026 · 19:32 IST

Acquisition

Updates on Acquisition

Attached

Company Update / Acquisition View filing →
25 September 2026 · 18:09 IST

Trading Window

Closure of Trading Window

Attached

Insider Trading / SAST / Closure of Trading Window View filing →
25 September 2026 · 18:06 IST

Board Meeting

Board Meeting Intimation for The Quarter And Half Year Ending On September 30, 2026

Dr. Lal Pathlabs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the un-audited (Standalone ....

Board Meeting / Board Meeting View filing →
24 September 2026 · 17:22 IST

Acquisition

Acquisition

Attached

Company Update / Acquisition View filing →
24 September 2026 · 17:20 IST

Outcome

Board Meeting Outcome for Outcome Of Board Meeting Dated September 24, 2026

Attached

Others / Outcome without intimation View filing →
4 September 2026 · 12:57 IST

Newspaper Publication

Newspaper Publication

Attached

Company Update / Newspaper Publication View filing →
27 August 2026 · 19:11 IST

Acquisition

Updates on Acquisition

Attached

Company Update / Acquisition View filing →
19 August 2026 · 18:24 IST

General

Inc orporation Of A Step-Down Subsidiary Company

Attached

Company Update / General View filing →
6 August 2026 · 16:22 IST

ESOP Allotment

Allotment of ESOP / ESPS

Attached

Company Update / Allotment of ESOP / ESPS View filing →
30 July 2026 · 19:36 IST

Concall Transcript

Earnings Call Transcript

Attached

Company Update / Earnings Call Transcript View filing →
24 July 2026 · 19:13 IST

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Attached

Company Update / Analyst / Investor Meet View filing →
24 July 2026 · 14:17 IST

Press Release

Press Release / Media Release

Attached

Company Update / Press Release / Media Release View filing →
24 July 2026 · 14:14 IST

Investor Presentation

Investor Presentation

Attached

Company Update / Investor Presentation View filing →
24 July 2026 · 13:57 IST

Dividend

Corporate Action-Board approves Dividend

Attached

Corp. Action / Dividend View filing →
24 July 2026 · 13:51 IST

Acquisition

Acquisition

Attached

Company Update / Acquisition View filing →
24 July 2026 · 13:49 IST

General

Grant Of Stock Options

Attached

Company Update / General View filing →
24 July 2026 · 13:47 IST

Record Date

The Record Date For The Purpose Of Payment Of Interim Dividend Shall Be July 30, 2026

Attached

Corp. Action / Record Date View filing →
24 July 2026 · 13:44 IST

Corporate Action

Dividend Updates

Attached

Corp Action / Dividend Updates View filing →
24 July 2026 · 13:42 IST

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting - July 24, 2026

Attached

Board Meeting / Outcome of Board Meeting View filing →
24 July 2026 · 13:39 IST

Results

Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30, 2026

Attached

Result / Financial Results View filing →

RSS feed for Dr. Lal PathLabs Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window